Conducting successful clinical trials and propelling the development of novel therapeutics forward cannot be done without the compliance of clinical research sites. In their role of carrying out the protocol and as the first-line contact with patients, oncology clinical site personnel have a direct impact on the success or failure of a trial.

Scimega Research’s Julie Martin builds a solid case on the effective clinical site relationship “how tos” for the long term to ensure the best possible outcomes for oncology clinical trial sponsors and the cancer patients participating in their cutting-edge trials.

Expedite suitable site identification using hard data sets
Optimize site engagement to attain maximum effectiveness for quality, timely data entry and query resolution
Address site staff turnover to effectively mitigate risk for patient safety
Best practices to meet and surpass enrollment targets

Bonus Offer: Register now and receive immediate access to the white paper, Expert Guidance to Key Advantages of Canadian Regulatory Landscape.

Keywords:

Speaker

Julie Martin, MSc, MBA, Lean certified, CEO & Co-Owner

Julie has been a part of the Scimega team since 2013. Her passion for the business stems from knowing its expert oncology clinical development services add distinct value to industry stakeholders when needed the most. As CEO, Julie’s vision is to secure the company’s long-term success by leveraging her in-depth industry expertise and business acumen. She equates that success with setting a clear vision for the organization’s continued sense of purpose. Julie is responsible for developing successful business strategies and leveraging industry opportunities all of which support the common vision she shares with her team. Her leadership and collaboration with the managing Board of Directors ensure the business excellence upon which Scimega has built its reputation. Julie plays a vital role in promoting Scimega’s expertise and showcasing Canada’s attributes as a formidable partner in global oncology drug development.

Message Presenter

Who Should Attend?

Clinical operations team leaders from small to mid-size biotech and biopharma companies managing complex oncology clinical studies will benefit the most from this webinar. Relevant job titles include:

Manager/Associate/Assistant Director
Director/Head/Vice President Operations
CEO
CMO

What You Will Learn

Attendees will learn:

Strategies to expedite site identification
How to optimize site engagement
Methods to effectively address site turnover
Best practices to meet and surpass enrollment targets

Xtalks Partner

Scimega

Scimega is a niche Canadian oncology CRO acting in Canada for the conduct of global cutting-edge oncology trials sponsored by small to mid-size biotechs.

In the face of an ever-changing clinical trial landscape our robust operations design guarantees sponsors the quickest global site start-up and fastest patient recruitment with assured premium quality data.

Skilled in collaborative vendor teaming, our oncology experts work with your team to devise innovative solutions specific to the unique challenges of your oncology clinical trial.

24 years of unparalleled Canadian oncology experience means our operational KPIs consistently surpass global industry norms.